TORRENT PHARMACEUTICALS
Back to Income Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹13,980 Cr | ₹11,516 Cr | ₹10,728 Cr | ₹9,620 Cr | ₹8,508 Cr |
What is the latest Revenue of TORRENT PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹13,980 Cr |
| Mar2025 | ₹11,516 Cr |
| Mar2024 | ₹10,728 Cr |
| Mar2023 | ₹9,620 Cr |
| Mar2022 | ₹8,508 Cr |
How is Revenue of TORRENT PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹13,980 Cr | 21.39 | |
| Mar2025 | ₹11,516 Cr | 7.35 | |
| Mar2024 | ₹10,728 Cr | 11.51 | |
| Mar2023 | ₹9,620 Cr | 13.07 | |
| Mar2022 | ₹8,508 Cr | - | |
Compare Revenue of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹190,848.6 Cr | -0.4% | 11% | 40.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹473,509.0 Cr | 0.6% | 6% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,881.0 Cr | 1.2% | 10.5% | 7.7% | Stock Analytics | |
| CIPLA | ₹113,894.0 Cr | -1.6% | -2.1% | -4.8% | Stock Analytics | |
| MANKIND PHARMA | ₹105,357.0 Cr | -1% | 3.7% | -5.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,062.8 Cr | -4.6% | -14.8% | -8.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -0.4% |
11% |
40.8% |
| SENSEX | -1.1% |
-0.2% |
-6.6% |
You may also like the below Video Courses